Comparative study of prophylactic effect of probiotic versus placebo on the urinary tract infection in children with the first simple urinary tract infection will admitted & refer to pediatric urgence & ward at Khalij Fars Hospital in Bushehr 2019-2020

Comparative study of prophylactic effect of probiotic versus placebo on the urinary tract infection in children with the first simple urinary tract infection

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200202046347N1

Enrollment

Registered

2020-03-20

Start date

2020-03-11

Completion date

Unknown

Last updated

2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preventive effect of probiotic on recurrent urinary tract infection in children.

Interventions

Intervention 1: Intervention group: Probiotics recipient

In this group all subjects use probiotic substance called Prokid (developed by Gostaresh Milad Farmed), during that the contents of a capsule dissolve in water every night for six months and then drin

In this group all subjects use water instead and drink water every night for six months. This will be taught to persons by specialized expertise.

Eligibility

Sex/Gender

All

Age

1 Years to 12 Years

Inclusion criteria

Inclusion criteria: All of 1 to 12 years old children with non-complicated urinary tract infection with positive urine culture

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Comparison of the prophylactic effect of probiotic and placebo on the incidence of urinary tract infection in children with the first simple urinary tract infection. Timepoint: Monthly for six months. Method of measurement: Take urine samples with sterile conditions using a catheter and send them to the laboratory.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Saber Moghateli

Boushehr University of Medical Sciences

sabermoghateli@gmail.com+98 77 3354 8936

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026